1. Home
  2. DOMH vs SNGX Comparison

DOMH vs SNGX Comparison

Compare DOMH & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

HOLD

Current Price

$3.37

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.75

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMH
SNGX
Founded
1967
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.3M
11.2M
IPO Year
2010
2006

Fundamental Metrics

Financial Performance
Metric
DOMH
SNGX
Price
$3.37
$0.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
227.9K
9.8M
Earning Date
05-12-2026
05-08-2026
Dividend Yield
23.45%
N/A
EPS Growth
34.03
57.03
EPS
N/A
N/A
Revenue
$123,104,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
578.41
N/A
52 Week Low
$2.69
$0.28
52 Week High
$8.40
$6.23

Technical Indicators

Market Signals
Indicator
DOMH
SNGX
Relative Strength Index (RSI) 52.01 54.74
Support Level $2.80 $0.28
Resistance Level $3.45 $1.48
Average True Range (ATR) 0.28 0.10
MACD -0.01 0.08
Stochastic Oscillator 35.21 53.81

Price Performance

Historical Comparison
DOMH
SNGX

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: